Results 1 to 10 of about 115,286 (266)
Phase 1, First‐In‐Human, Single‐/Multiple‐Ascending Dose Study of Iluzanebart in Healthy Volunteers [PDF]
Objective To evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of iluzanebart, a fully human monoclonal antibody TREM2 (triggering receptor expressed on myeloid cells 2) agonist, after single‐ (SAD) and multiple‐ascending‐dose ...
Andreas Meier+8 more
doaj +2 more sources
Helmeted hornbills (Rhinoplax vigil, J.R. Forster, 1781) are ‘Critically Endangered’ due to illegal hunting for their casques which are carved and traded for ornamental purposes.
Chloe E.R. Hatten+6 more
doaj +2 more sources
Colorectal cancer is the third most diagnosed cancer in the United States. Five-year survival rates remain low and many patients will develop liver metastasis.
Vedin Barve+2 more
exaly +3 more sources
Background: Gemogenovatucel-T (Vigil) is a triple-function autologous tumor cell immunotherapy which expresses granulocyte-macrophage colony-stimulating factor and decreases expression of furin and downstream TGF-β1 and TGF-β2.
John J Nemunaitis
exaly +2 more sources
Tibor Hajas's video and article.
Tibor Hajas
doaj +2 more sources
Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapy [PDF]
John J Nemunaitis
exaly +4 more sources
Exome sequencing shows same pattern of clonal tumor mutational burden, intratumor heterogenicity and clonal neoantigen between autologous tumor and Vigil product [PDF]
Retrospective data support overall survival (OS) advantage to high clonal tumor mutation burden (cTMB), high clonal neoantigen load (cNEO) and low intratumor heterogeneity (ITH) in cancer patients who receive immunotherapy.
David Willoughby+10 more
doaj +2 more sources
3D engineered scaffold for large-scale Vigil immunotherapy production [PDF]
Previously, we reported successful cellular expansion of a murine colorectal carcinoma cell line (CT-26) using a three-dimensional (3D) engineered extracellular matrix (EECM) fibrillar scaffold structure.
Fabienne Kerneis+13 more
doaj +2 more sources
Aim: To determine the relationship between gene expression profile (GEP) and overall survival (OS) by NanoString following treatment with Vigil. Patients and Methods: Recurrent ovarian cancer patients (n = 21) enrolled in prior clinical trials.
Rodney P Rocconi+2 more
exaly +3 more sources
Recuperación colectiva de la Biblioteca Popular Constancio C. Vigil
El presente artículo tiene como objetivo narrar la experiencia del Proyecto de extensión “Recuperación Colectiva de la Biblioteca Vigil”. El mismo resultó del trabajo en conjunto entre la currícula de grado del Taller de Proyecto Arquitectónico, el ...
Susana Paganini
doaj +2 more sources